SKYSTAR
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Mar 2025)
What this means for you
Registered since 26 Nov 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88976053
- Registration number
- 5922902
- Mark type
- Stylized text
- Filed
- 17 Sept 2018
- Published for opposition
- 05 Feb 2019
- Registered
- 26 Nov 2019
- Attorney of record
- Peter Kunin
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals, namely, small molecule therapies for the correction of RNA expression, used in the treatment of cancers, neurological diseases, and other diseases
Owner
- Skyhawk Therapeutics, Inc., Waltham, MA, US
- Skyhawk Therapeutics, Inc., Cambridge, MA, US
- Skyhawk Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 31 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Mar 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Dec 2024 — TEAS SECTION 8 & 15 RECEIVED
- 26 Nov 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Feb 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Feb 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Nov 2019 — REGISTERED-PRINCIPAL REGISTER
- 23 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Oct 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Oct 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Oct 2019 — STATEMENT OF USE PROCESSING COMPLETE